17:00 – 19:00 | Sunday, 30 June, 2013 Session Room 3 Kuala Lumpur Convention Centre (KLCC) Kuala Lumpur, Malaysia Chair: Nicholas Paton.

Slides:

Advertisements

Similar presentations

Introduction Charles B. Hicks, MD Professor of Medicine Associate Director, Duke AIDS Research and Treatment Center Duke University Medical Center Durham,

Advertisements

Rethinking Lower Blood Pressure Goals for Diabetic Patients with Coronary Artery Disease – Findings from the INternational VErapamil SR – Trandolapril.

Advances in IM Therapy Douglas H. Hughes, MD Vice Chair of Psychiatry Boston University School of Medicine Boston, Massachusetts.

Session Title Presented by: Name, Institution Day, Date, Time ##:## Session ID ###

Innovative Strategies for the Management of HIV Infection Dual therapies without NRTIs Jean-Guy Baril, MD Clinique médicale du Quartier Latin CHUM This.

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 How to manage virologic non- responders, non-genotype 1, relapsers IAS 2013, Session: HCV.

Advances in the Treatment of Chronic Hepatitis C Gregory T Everson, MD Professor of Medicine Director of Hepatology University of Colorado Denver.

A pilot study to determine the prevalence of HIV in individuals presenting for care with selected conditions: Preliminary results: the HIV in Europe Indicator.

Examinations Information. Examination Timetables Your personal copy of the exam timetable will be sent home before every exam session from now on. You.

Page 1 of 4 Morning Session (A) Practice Management Registration TimeSubjectSpeakerNotes Integrated Care System Claire Heneghan.

Hale & Tempest Global Generics Marketplace Dr. Brian W Tempest UK 18,19,20 March 2014.

Welcome and Introduction Moderator: John Bartlett, MD Discussants: Cal Cohen, MD Ian Frank, MD Moderator: John Bartlett, MD Discussants: Cal Cohen, MD.

Anticoagulation and AF: Emerging Insights

Hale & Tempest Global Pharma 2014 Dr. Brian W Tempest Mumbai August 2014.

2014. Diamond Members  Alexion  Bristol Myers Squibb  Cardinal Health  Eisai, Inc.  Foundation Medicine  Genomic Health  McKesson  MedImmune.

ADAP ADVOCACY ASSOCIATION 2013 HIV/HCV CO-INFECTION SUMMIT Lynda Dee Fair Pricing Coalition PAPS & CO-PAY PROGRAMS.

THE BODY PRO The HIV Resource for Health Care Professionals Copyright © 2009 The HealthCentral Network, Inc. All rights reserved. This activity is jointly.

Hale & Tempest Global Pharma 2014 Dr. Brian W Tempest Mumbai August 2014.

Individualizing Care in HIV: A Critical Review of Treatment Options Presented by The Johns Hopkins University School of Medicine Produced in collaboration.

How Much AF is Too Much AF? Do I Initiate Anticoagulation Based on AF Detected on Device Monitoring? Kenneth W. Mahaffey, MD, FACC Professor of Medicine,

1 UNWANTED/WASTE PHARMACEUTICALS NATIONAL DIALOGUE June 19-20, 2008 Sacramento, CA Post-Consumer Pharmaceutical Stewardship Association.

Page 1 Increasing rates of earlier antiretroviral treatment associated with elevated levels of optimal virologic response among HIV-positive illicit drug.

REGISTRATION PROCESS FOR THE TOEIC TEST IN FCU TEST DATE: 17 JUNE, 2015.

Medicines Patent Pool and Seychelles A primer For more information visit:

Membership Ordinary Members – 38 Associate Members – 18 Total – 56

Managing Patients Who Cannot Take Anticoagulants Kenneth W. Mahaffey, MD, FACC Professor of Medicine, Cardiology Faculty Associate Director, DCRI Director,

1 [Conference title] [Conference_Name] Session XXXX: [session_title] [title line 2] [title line 3] Organizers / Chairs:  yyyy, zzzz (name, affiliation)

Hit Hard, Hit Early: When to Treat and With What? Brian G. Gazzard, MD, Moderator Julio Montaner, MD Calvin J. Cohen, MD, MS.

Welcome to the Young Statisticians Writing Webinar 1 We will start at 4pm GMT Your chair is Sofya Gorelova Statistician at HMRC and Young Statisticians.

SEOUL, S. KOREA PYONGYANG, N. KOREA KUALA LUMPUR, MALAYSIA

#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.

Different key fields for different cases More to Learn A key field is a field that can be used to uniquely identify one specific record from other records.

ADAP ADVOCACY ASSOCIATION 2013 HIV/HCV CO-INFECTION SUMMIT Lynda Dee Fair Pricing Coalition DRUG DEVELOPMENT & PRICING.

Global Respiratory Drugs Market WEBSITE Single User License: US$ 2500 No of Pages: 120 Corporate User License: US$

COLLABORATE 13- OAUG FORUM OAUG Speaker Orientation March 19 th at 3:00 PM March 21 st at 11:00 AM.

HIV and Hepatitis C Annual Update 2012 Supported by educational grants from.

Hepatitis C Drugs Market & Pipeline Drugs Analysis to 2019 With special emphasis on Hepatitis C Approved Drugs, Pipeline Drugs and Clinical Trial Analysis.

January 2005© design team kuala lumpur (60 3)

Hepatitis C Drugs Market & Pipeline Drugs Analysis to 2019 With special emphasis on Hepatitis C Approved Drugs, Pipeline Drugs and Clinical Trial Analysis.

Where our experience delivers measurable results… JLyonsMarketing J Lyons Marketing a manufacturer representative company since 1987… “Our primary objective.

Global Orphan Drug Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Phone No.: +1 (214) id:

Patents & health: focus on access

FACULTY/PRESENTER DISCLOSURE

2017 NOAA Satellite Conference JPSS Satellite Training Session

ADAP ADVOCACY ASSOCIATION 2013 HIV/HCV CO-INFECTION SUMMIT

ADAP ADVOCACY ASSOCIATION 2013 HIV/HCV CO-INFECTION SUMMIT

Wheelchair Manufacturers

David Lim, Julie Hepworth, Evan Siegel, Mieke van Driel, & Lisa Nissen

Managing symptomatic asthma in primary care: The personalised approach

Proud to Present Good Morning & welcome to the 11th Annual VHVI Symposium Thank you all for coming today Our planning committee has put together an exciting.

Stefan Gijssels, Janssen Pharmaceutica

HIV Drugs Market HIV Drug Market to Reach $26,458 Million, Globally by 2022.

Chloe Orkin British HIV Association Queen Mary University London

Concert Rules Set your mobile phones in the physical alert / silent mode. Do NOT have your ringer on during this class. When you want to comment please.

Monday, 23 July, 10:15-12:15 Hall 11B, RAI Amsterdam

UNIVERSITY EXPERIENCE Survey

Wednesday 5th October Mary Ward House, London

Buy Generic Medicines Online at Discounted Prices.

Presenter #1 • Presenter #2 • Presenter #3 Presenter #4 • Presenter #5

Chairs Sven Mahner (Germany) Antonio González-Martín (Spain)

The Hong Kong Geriatrics Society Inter-hospital Geriatric Meeting

ONE Safety Patient Engagement – Website Enhancement Opportunity

Presenter # 1 • Presenter # 2 • Presenter # 3

Speaker Name Job Title Campus/Organization

ADAP Advocacy Association 2012 ADAP Solution Summit

Module 4 Part 1 Selecting Aims

Instructions for using this template

Instructions for using this template

Presentation transcript:

17:00 – 19:00 | Sunday, 30 June, 2013 Session Room 3 Kuala Lumpur Convention Centre (KLCC) Kuala Lumpur, Malaysia Chair: Nicholas Paton

OPENING REMARKS Dr. Nicholas Paton Singapore

2 Agenda 17:00–17:05Opening Remarks Nicholas Paton, Singapore 17:05–17:35Cryptococcal meningitis and tuberculosis Andrew Kambugu, Uganda 17:35–18:05HIV-associated neurocognitive disorder (HAND) Patrick Li, Hong Kong 18:05–18:35Hepatitis B and C Jürgen Rockstroh, Germany 18:35–18:50Discussion / Q&APanel 18:50–19:00Closing Remarks Nicholas Paton, Singapore

3 Disclosures Speakers have acted as advisor, received speaker fees/meeting expenses, or received research grants/drug support from: Dr. Nicholas Paton: Abbott, AbbVie, Genentech, Gilead, GSK, Janssen diagnostics, Merck, Pfizer Dr. Andrew Kambugu: AbbVie, MSD Dr. Patrick Li: AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen Pharmaceutica, Merck Sharp & Dohme, ViiV Healthcare Dr. Jürgen Rockstroh: Abbott, AbbVie, BI, Bionor, BMS, Janssen, Merck, Novartis, Pfizer, Roche, Tibotec, Vertex, ViiV

4 Housekeeping Please switch mobile phones and pagers to vibrate Kindly do not use flash photography To ask a question at the end of the symposium: – Please fill in question card and hand to a member of staff Please complete the evaluation form at the end of the symposium and hand it to a member of staff as you leave